Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of liraglutide injection versus Victoza in adults with type 2 diabetes inadequately controlled on metformin
CTR20211086Phase 3Active
- Sponsor
- China Resources Double-Crane Pharmaceutical
- Start
- Aug 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by China Resources Double-Crane Pharmaceutical. Started Aug 2021; status: active.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20211086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211086.